Scientific Review Board

Members from two different advisory groups, the Scientific Review Board and the Business Review Board, review all grant applications submitted to the ADDF. The Scientific Review Board is composed of over 150 scientists who encompass various areas of expertise within Alzheimer’s research.

  • Gunnar K. Gouras, MD
    Weill Medical College of Cornell University

  • Illana Gozes, PhD
    Tel Aviv University

  • Allan M. Green, MD, PhD, JD
    Allan M. Green Esq., LLC

  • Barry D. Greenberg, PhD
    University Health Network

  • Francine Grodstein, ScD
    Brigham and Women's Hospital

  • John Hardy, PhD
    UCL Institute of Neurology

  • Joseph A. Helpern, PhD
    Medical University of South Carolina

  • Jim Hendrix, PhD
    Alzheimer's Association

  • Lawrence Honig, MD, PhD
    Columbia University

  • Orest Hurko, MD
    Biologics Consulting Group, Inc.

  • Xiong Jiang, PhD
    Georgetown University

  • Carl Johnson, PhD
    Hereditary Disease Foundation

  • Corinne Jolivalt, PhD
    University of Southern California, San Diego

  • Graham Jones, PhD
    Northeastern University

  • Andrew Kertesz, MD
    University of Western Ontario

Go to top